TNBTD
NVO

Trustmark National Bank Trust Department’s Novo Nordisk NVO Stock Holding History

Trustmark National Bank Trust Department’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,724
Closed -$205K – 303
2024
Q3 		$205K Buy
1,724
+14
+0.8% +$1.87K 0.02% 289
2024
Q2 		$244K Buy
+1,710
New +$227K 0.02% 266

Other funds holding NVO

Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $42.5B AUM 18.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Trustmark National Bank Trust Department's NVO Position: Q4 2024 in Review

Trustmark National Bank Trust Department sold out of Novo Nordisk (NVO) in Q4 2024, closing a stake of 1,724 shares — an estimated $205K sold.

Trustmark National Bank Trust Department first reported a position in NVO in Q2 2024 and held it in 2 quarters. The position peaked at $244K in Q2 2024. 1,667 funds tracked by Wall St. Rank hold NVO as of Q4 2024.

  • Trustmark National Bank Trust Department reported no remaining Novo Nordisk position as of Q4 2024 after selling out during the quarter.
  • Trustmark National Bank Trust Department sold 1,724 Novo Nordisk shares in Q4 2024, an estimated $205K.
  • Trustmark National Bank Trust Department first reported a position in Novo Nordisk in Q2 2024 and held it in 2 quarters.
  • Trustmark National Bank Trust Department's Novo Nordisk position peaked at $244K in Q2 2024.
  • 1,667 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2024.

Based on Trustmark National Bank Trust Department's 13F filing for Q4 2024, filed 13 Feb 2025.